勘误：用于治疗导管相关尿路感染及相关生物被膜的噬菌体鸡尾酒疗法的研发
Corrigendum: Development of phage cocktails to treat catheter-associated urinary tract infection and associated biofilms.
作者信息
Sanchez Belkys C, Heckmann Emmaline R, Green Sabrina I, Clark Justin R, Kaplan Heidi B, Ramig Robert F, Muldrew Kenneth L, Hines-Munson Casey, Skelton Felicia, Trautner Barbara W, Maresso Anthony W
机构信息
Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
Department of Microbiology and Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX, United States.
出版信息
Front Microbiol. 2022 Aug 9;13:953136. doi: 10.3389/fmicb.2022.953136. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fmicb.2022.796132.].
摘要
[本文更正了文章DOI：10.3389/fmicb.2022.796132。]
相似文献
1
Corrigendum: Development of phage cocktails to treat catheter-associated urinary tract infection and associated biofilms.
Front Microbiol. 2022 Aug 9;13:953136. doi: 10.3389/fmicb.2022.953136. eCollection 2022.
2
Development of Phage Cocktails to Treat Catheter-Associated Urinary Tract Infection and Associated Biofilms.
Front Microbiol. 2022 May 10;13:796132. doi: 10.3389/fmicb.2022.796132. eCollection 2022.
3
Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic Isolates, India.
Pathogens. 2022 Nov 30;11(12):1448. doi: 10.3390/pathogens11121448.
4
Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.
J Appl Microbiol. 2018 Nov;125(5):1253-1265. doi: 10.1111/jam.14026. Epub 2018 Jul 18.
5
Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
Antimicrob Agents Chemother. 2012 Sep;56(9):4738-45. doi: 10.1128/AAC.00447-12. Epub 2012 Jun 25.
6
Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
J Appl Microbiol. 2022 Apr;132(4):3387-3404. doi: 10.1111/jam.15439. Epub 2022 Jan 17.
7
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
mSphere. 2022 Aug 31;7(4):e0034522. doi: 10.1128/msphere.00345-22. Epub 2022 Aug 3.
8
Anti-Biofilm Effect of Bacteriophages and Antibiotics against Uropathogenic .
Antibiotics (Basel). 2022 Nov 26;11(12):1706. doi: 10.3390/antibiotics11121706.
9
Disperse red 15 (DR15) impedes biofilm formation of uropathogenic Escherichia coli.
Microb Pathog. 2020 Jan;138:103772. doi: 10.1016/j.micpath.2019.103772. Epub 2019 Oct 4.
10
Coating of silicone with mannoside-PAMAM dendrimers to enhance formation of non-pathogenic Escherichia coli biofilms against colonization of uropathogens.
Acta Biomater. 2017 Dec;64:200-210. doi: 10.1016/j.actbio.2017.10.008. Epub 2017 Oct 9.
引用本文的文献
1
The rise, fall, and resurgence of phage therapy for urinary tract infection.
EcoSal Plus. 2024 Dec 12;12(1):eesp00292023. doi: 10.1128/ecosalplus.esp-0029-2023. Epub 2024 Jan 11.
2
Phage Therapy-Challenges, Opportunities and Future Prospects.
Pharmaceuticals (Basel). 2023 Nov 22;16(12):1638. doi: 10.3390/ph16121638.
Zotero 插件